What does Imagion Biosystems Limited do?

Imagion Biosystems Limited (IBXXF) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is IBXXF's market cap?

Imagion Biosystems Limited (IBXXF) has a market capitalization of approximately $6.5 million, as of August 26, 2026, based on the most recent share price and shares outstanding.

Does IBXXF pay a dividend?

No — Imagion Biosystems Limited (IBXXF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Imagion Biosystems Limited (IBXXF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

IBXXF

Imagion Biosystems Limited

OTC·Medical, Diagnostics & Research · Healthcare

$0.01$0.00+0.00%

Market cap$6.48M·Market closed·Aug 26 8:00 PM UTC

Price Chart

$0.01+$0.00 (+0.00%)today

−88.00%CAGR −34.61%

Select date range

FromTo

Sep 21, 2020Aug 28, 2021 → Aug 27, 2026· 5.0 yrsAug 27, 2026

Key Metrics

IBXXF does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateFeb 26

Last Report DateFeb 25

Reported vs Estimate−$0.00

Earnings Surprise—

FinancialsFinancials Tab

RevenueA$0.00

Net Income−A$4.63M

Net Margin—

Operating Cash Flow−A$4.04M

Capital ExpendituresA$4.49

Free Cash Flow−A$4.04M

Return on Equity—

Return on Invested Capital184.7%

Net DebtA$2.16M

Value Graph

PRO

See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.

Click below to see what's inside, then upgrade to unlock for IBXXF and 80,000+ other tickers.

EPS · Price vs. Fair Value Price Fair

Income Statement Flow

PRO

See exactly how IBXXF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for IBXXF and 80,000+ other tickers.

About Imagion Biosystems Limited

Imagion Biosystems Limited is dedicated to advancing medical imaging through innovative technologies centered on superparamagnetic relaxometry. The company's core mission is to enable the early detection of diseases, with a particular focus on cancer, and to monitor the efficacy of therapeutic interventions. Its operational scope encompasses nanotechnology, biotechnology, and cancer diagnostics, all built upon its proprietary superparamagnetic relaxometry platform. Imagion's product pipeline includes MagSense, which is currently undergoing Phase I clinical trials for its application in…

CEO: Robert Romeo Proulx
Sector: Healthcare
Industry: Medical - Diagnostics & Research
Exchange: OTC
Employees: 11
Website: imagionbiosystems.com

Peers

Grey Matters Health Inc.

Latest News

News Tab

No recent news available.

Frequently Asked Questions About IBXXF

What does Imagion Biosystems Limited do?: Imagion Biosystems Limited (IBXXF) operates in the Medical - Diagnostics & Research industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is IBXXF's market cap?: Imagion Biosystems Limited (IBXXF) has a market capitalization of approximately $6.5 million, as of August 26, 2026, based on the most recent share price and shares outstanding.
Does IBXXF pay a dividend?: No — Imagion Biosystems Limited (IBXXF) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is IBXXF profitable?: Imagion Biosystems Limited (IBXXF) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.